Drug Type Small molecule drug |
Synonyms Ambroxol Hydrochloride and Clenbuterol Hydrochloride, 氨溴特罗 |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (17 Mar 2004), |
Regulation- |
Molecular FormulaC12H19Cl3N2O |
InChIKeyOPXKTCUYRHXSBK-UHFFFAOYSA-N |
CAS Registry21898-19-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Diseases | CN | 17 Mar 2004 |